Comments on “The Efficacy of 12 Weeks of Sofosbuvir, Daclatasvir, and Ribavirin in Treating Hepatitis C Patients with Cirrhosis, Genotypes 1 and 3”
No Thumbnail Available
Date
2017-03-31
0000-0001-8686-9986 Journal Title
Journal ISSN
Volume Title
Publisher
Brieflands
Abstract
This article does not have an abstract.